Incannex Healthcare (IXHL) Retained Earnings (2020 - 2026)
Incannex Healthcare (IXHL) posted Retained Earnings of $253.2 million for Q1 2026, up 2.5% sequentially from $247.0 million in Q4 2025, and up 85.03% YoY from $136.8 million in Q1 2025.
Incannex Healthcare (IXHL) Retained Earnings (2020 - 2026) Analysis & Trends
Incannex Healthcare has reported Retained Earnings for 7 years, with the latest figure at $253.2 million in Q1 2026.
- Quarterly Retained Earnings rose 85.03% year-over-year to $253.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $253.2 million (up 85.03% YoY) and the FY2025 annual result came in at $174.0 million, up 39.0% from the prior year.
- Retained Earnings climbed to $253.2 million in Q1 2026 per IXHL's latest filing, from $247.0 million in the prior quarter.
- Over five years, Retained Earnings peaked at $253.2 million in Q1 2026 and troughed at -$67.3 million in Q4 2022.
- A 5-year average of $128.0 million and a median of $125.7 million in 2024 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2023: Retained Earnings slumped 33.96% in 2022, then surged 297.79% in 2023.
- Over 5 years, Retained Earnings stood at -$67.3 million in 2022, then jumped by 278.07% to $119.9 million in 2023, then climbed by 5.39% to $126.4 million in 2024, then soared by 95.52% to $247.0 million in 2025, then gained by 2.5% to $253.2 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered $253.2 million, $247.0 million, and $243.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.75 Bn |
| 10 | Incannex Healthcare | 43.22 Mn | 43.22 Mn | - | 253.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 253.22 Mn |
| Dec 31, 2025 | 247.04 Mn |
| Sep 30, 2025 | 243.84 Mn |
| Jun 30, 2025 | 174.05 Mn |
| Mar 31, 2025 | 136.85 Mn |
| Dec 31, 2024 | 126.35 Mn |
| Sep 30, 2024 | 125.68 Mn |
| Jun 30, 2024 | 125.22 Mn |
| Mar 31, 2024 | 122.00 Mn |
| Dec 31, 2023 | 119.89 Mn |
| Jun 30, 2023 | 116.29 Mn |
| Dec 31, 2022 | -67.32 Mn |
| Jun 30, 2022 | -58.79 Mn |
| Jun 30, 2021 | -43.89 Mn |
| Jun 30, 2020 | -32.52 Mn |